Parents of Epileptic Teen Plead For Easier Access to CBD Prescriptions

October 31, 2019 08:00:12

Young Bailey Rankmore suffers from Lennox-Gastaut syndrome, a particularly nasty form of epilepsy that sees him having up to 100 seizures on a daily basis. He is the latest in an increasing number of people in the UK who have used CBD to help manage severe conditions.

His parents, Craig and Rachel Rankmore, have pleaded with the NHS (National Health Service) to make it easier to access prescriptions for medical cannabis. After running out of conventional treatments for their son, they decided to think outside the box, settling on a private CBD prescription when he was fourteen. “He’d have a minimum of 100 big seizures a day,” they said, “the ones people associate with shaking on the floor. We’d seen…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com